4-(Methylthio)quinoline

Catalog No.: 
ACCDEL740
CAS No.: 
46000-25-3
Molecular Formula: 
C10H9NS
Molecular Weight: 
175.26
4-(Methylthio)quinoline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$94.00In stockInquiry
250mg97%$183.00In stockInquiry
1g97%$535.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(Methylthio)quinoline
IUPAC Name4-(methylthio)quinoline
Molecular FormulaC10H9NS
Molecular Weight175.26
SMILESCSC1=CC=NC2=CC=CC=C12
InChI KeyUPWGLVMHTJEWLR-UHFFFAOYSA-N
Synonym4-methylsulfanylquinoline;Quinoline, 4-(methylthio)-;4-(Methylthio)quinoline
CAS No.46000-25-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACCDEL740 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIZER206 route compound structure diagram
    ACIZER206611-35-8In Stock
  4. Then
  5. ACCDEL740 route product structure diagram
    ACCDEL74046000-25-3In Stock
Inquiry

2. ACCDEL740 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIZER206 route compound structure diagram
    ACIZER206611-35-8In Stock
  4. Then
  5. ACCDEL740 route product structure diagram
    ACCDEL74046000-25-3In Stock
Inquiry

3. ACCDEL740 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLMOQ103 route compound structure diagram
    ACLMOQ1033964-04-3In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCDEL740 route product structure diagram
    ACCDEL74046000-25-3In Stock
Inquiry

Comments (0)